BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22818167)

  • 1. BCL10 down-regulation in peripheral T-cell lymphomas.
    Rossi M; Agostinelli C; Righi S; Sabattini E; Bacci F; Gazzola A; Pileri SA; Piccaluga PP
    Hum Pathol; 2012 Dec; 43(12):2266-73. PubMed ID: 22818167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bcl10 expression, rearrangement and mutation in MALT lymphoma: correlation with expression of nuclear factor-kappaB.
    Ohshima K; Muta H; Kawasaki C; Muta K; Deyev V; Kanda M; Kumano Y; Podack ER; Kikuchi M
    Int J Oncol; 2001 Aug; 19(2):283-9. PubMed ID: 11445840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALT lymphoma with t(14;18)(q32;q21)/IGH-MALT1 is characterized by strong cytoplasmic MALT1 and BCL10 expression.
    Ye H; Gong L; Liu H; Hamoudi RA; Shirali S; Ho L; Chott A; Streubel B; Siebert R; Gesk S; Martin-Subero JI; Radford JA; Banerjee S; Nicholson AG; Ranaldi R; Remstein ED; Gao Z; Zheng J; Isaacson PG; Dogan A; Du MQ
    J Pathol; 2005 Feb; 205(3):293-301. PubMed ID: 15682443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear expression of BCL10 or nuclear factor kappa B predicts Helicobacter pylori-independent status of early-stage, high-grade gastric mucosa-associated lymphoid tissue lymphomas.
    Kuo SH; Chen LT; Yeh KH; Wu MS; Hsu HC; Yeh PY; Mao TL; Chen CL; Doong SL; Lin JT; Cheng AL
    J Clin Oncol; 2004 Sep; 22(17):3491-7. PubMed ID: 15337797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling of T-cell lymphomas differentiates peripheral and lymphoblastic lymphomas and defines survival related genes.
    Martinez-Delgado B; Meléndez B; Cuadros M; Alvarez J; Castrillo JM; Ruiz De La Parte A; Mollejo M; Bellas C; Diaz R; Lombardía L; Al-Shahrour F; Domínguez O; Cascon A; Robledo M; Rivas C; Benitez J
    Clin Cancer Res; 2004 Aug; 10(15):4971-82. PubMed ID: 15297397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of NF-kappaB pathway genes among peripheral T-cell lymphomas.
    Martínez-Delgado B; Cuadros M; Honrado E; Ruiz de la Parte A; Roncador G; Alves J; Castrillo JM; Rivas C; Benítez J
    Leukemia; 2005 Dec; 19(12):2254-63. PubMed ID: 16270046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-2 induces NF-kappaB activation through BCL10 and affects its subcellular localization in natural killer lymphoma cells.
    Chan KK; Shen L; Au WY; Yuen HF; Wong KY; Guo T; Wong ML; Shimizu N; Tsuchiyama J; Kwong YL; Liang RH; Srivastava G
    J Pathol; 2010 Jun; 221(2):164-74. PubMed ID: 20235165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of BCL10 in cervical cancer has a role in the regulation of cell growth through the activation of NF-κB-dependent cyclin D1 signaling.
    Kuo SH; Chou CH; Cheng AL; Wang CW; Chen YH; Chen RJ
    Gynecol Oncol; 2012 Aug; 126(2):245-51. PubMed ID: 22564715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forkhead box P1 overexpression and its clinicopathologic significance in peripheral T-cell lymphoma, not otherwise specified.
    Yamada S; Sato F; Xia H; Takino H; Kominato S; Ri M; Ishida T; Iida S; Inagaki H; Yamada K
    Hum Pathol; 2012 Aug; 43(8):1322-7. PubMed ID: 22401769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral T cell and natural killer (NK) T cell lymphomas: a clinicopathological study from a single Australian centre.
    McKelvie PA; Thompson PA; Tam CS
    Histopathology; 2012 Aug; 61(2):212-23. PubMed ID: 22716228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MALT1, BCL10 and FOXP1 in salivary gland mucosa-associated lymphoid tissue lymphomas.
    Borovecki A; Korac P; Ventura RA; Perisa MM; Banham AH; Dominis M
    Pathol Int; 2007 Jan; 57(1):47-51. PubMed ID: 17199743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression analysis of angioimmunoblastic lymphoma indicates derivation from T follicular helper cells and vascular endothelial growth factor deregulation.
    Piccaluga PP; Agostinelli C; Califano A; Carbone A; Fantoni L; Ferrari S; Gazzola A; Gloghini A; Righi S; Rossi M; Tagliafico E; Zinzani PL; Zupo S; Baccarani M; Pileri SA
    Cancer Res; 2007 Nov; 67(22):10703-10. PubMed ID: 18006812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BCL10 expression in ocular adnexal lymphomas.
    Vejabhuti C; Harris GJ; Erickson BA; Nishino H; Chevez-Barrios P; Chang CC
    Am J Ophthalmol; 2005 Nov; 140(5):836-843. PubMed ID: 16310461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral T-cell lymphoma with follicular T-cell markers.
    Rodríguez-Pinilla SM; Atienza L; Murillo C; Pérez-Rodríguez A; Montes-Moreno S; Roncador G; Pérez-Seoane C; Domínguez P; Camacho FI; Piris MA
    Am J Surg Pathol; 2008 Dec; 32(12):1787-99. PubMed ID: 18779728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus negative clonal plasma cell proliferations and lymphomas in peripheral T-cell lymphomas: a phenomenon with distinctive clinicopathologic features.
    Balagué O; Martínez A; Colomo L; Roselló E; Garcia A; Martínez-Bernal M; Palacín A; Fu K; Weisenburger D; Colomer D; Burke JS; Warnke RA; Campo E
    Am J Surg Pathol; 2007 Sep; 31(9):1310-22. PubMed ID: 17721185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spectrum of peripheral T-cell lymphomas.
    O'leary H; Savage KJ
    Curr Opin Hematol; 2009 Jul; 16(4):292-8. PubMed ID: 19509496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of caspase-8 activity caused by overexpression of BCL10 contributes to the pathogenesis of high-grade MALT lymphoma.
    Chen Y; Yang Y; Sun M; Yan Z; Wu L; Cui X; Zhang G; Morris SW; Zhang Q
    Pediatr Blood Cancer; 2012 Jun; 58(6):865-71. PubMed ID: 21954216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. BCL10 in malignant lymphomas--an evaluation using fluorescence in situ hybridization.
    Achuthan R; Bell SM; Carr IM; Leek JP; Roberts P; Horgan K; Markham AF; Selby PJ; MacLennan KA
    J Pathol; 2002 Jan; 196(1):59-66. PubMed ID: 11748643
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivating mutations and overexpression of BCL10, a caspase recruitment domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).
    Zhang Q; Siebert R; Yan M; Hinzmann B; Cui X; Xue L; Rakestraw KM; Naeve CW; Beckmann G; Weisenburger DD; Sanger WG; Nowotny H; Vesely M; Callet-Bauchu E; Salles G; Dixit VM; Rosenthal A; Schlegelberger B; Morris SW
    Nat Genet; 1999 May; 22(1):63-8. PubMed ID: 10319863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant nuclear BCL10 expression and lack of t(11;18)(q21;q21) in primary cutaneous marginal zone B-cell lymphoma.
    Gallardo F; Bellosillo B; Espinet B; Pujol RM; Estrach T; Servitje O; Romagosa V; Barranco C; Boluda S; García M; Solé F; Ariza A; Serrano S
    Hum Pathol; 2006 Jul; 37(7):867-73. PubMed ID: 16784987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.